No Incidence of BRAF Mutations in Salivary Gland Carcinomas—Implications for Anti-EGFR Therapies
Main Authors: | Regine Dahse, Katrin Kromeyer-Hauschild, Alexander Berndt, Hartwig Kosmehl |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2009-01-01
|
Series: | Journal of Biomedicine and Biotechnology |
Online Access: | http://dx.doi.org/10.1155/2009/501736 |
Similar Items
-
Consistent absence of BRAF mutations in salivary gland carcinomas
by: Nooshin Mohtasham, et al.
Published: (2017-06-01) -
CELL SEPARATION AND GENE EXPRESSION ANALYSIS IN A TUMOR-STROMA INTERACTION MODEL
by: Regine Dahse, et al.
Published: (2011-05-01) -
Dual EGFR and BRAF blockade overcomes resistance to vemurafenib in BRAF mutated thyroid carcinoma cells
by: Tiziana Notarangelo, et al.
Published: (2017-10-01) -
Evaluation of EGFR, KRAS and BRAF gene mutations in renal cell carcinoma
by: Omer Bayrak, et al.
Published: (2014-08-01) -
Mitochondrial mutations in adenoid cystic carcinoma of the salivary glands.
by: Suhail K Mithani, et al.
Published: (2009-12-01)